Summary
Regeneron Pharmaceuticals, Inc. (REGN) filed an 8-K on October 28, 2010, to report its financial and operating results for the third quarter ended September 30, 2010. The report primarily serves to furnish a press release detailing these results, which is attached as an exhibit. Investors should refer to the full press release (Exhibit 99.1) for comprehensive details on the company's performance during the quarter. This filing does not contain new material business developments beyond the quarterly financial update.
Key Highlights
- 1Filing reports third quarter 2010 financial and operating results.
- 2Results announced via press release dated October 28, 2010.
- 3Press release furnished as Exhibit 99.1 to the 8-K filing.
- 4The filing's primary purpose is to provide investors with the Q3 2010 earnings information.
- 5No other material events or business updates are disclosed in the 8-K itself.